Elevated risks of death for diabetes mellitus and cardiovascular diseases in Italian AIDS cases

AIDS Research and Therapy

Volumn 7, Issue , 2010, Pages

  Serraino, Diego ^a   Bruzzone, Silvia ^b   Zucchetto, Antonella ^a   Suligoi, Barbara ^c   De Paoli, Angela ^a   Pennazza, Simona ^b   Camoni, Laura ^c   Dal Maso, Luigino ^a   De Paoli, Paoli ^a   Rezza, Giovanni ^c  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b ITALIAN NATIONAL INSTITUTE OF STATISTICS   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC DISEASE; CONTROLLED STUDY; DEATH CERTIFICATE; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 77952490522     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-7-11     Document Type: Article

References (18)

1. CASCADE Collaboration Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2000, 20:741-749. CASCADE Collaboration.
2. Palella FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD, . HIV Outpatient Study Investigators Mortality in the highly active antiretroviral therapy era. Changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006, 43:27-34. 10.1097/01.qai.0000233310.90484.16, 16878047, HIV Outpatient Study Investigators.
3. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006, 145:397-406.
4. Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, Hirschel B, Cavassini M, Bernasconi E, Schmid P, Egger M, Weber R, . Swiss HIV Cohort Study Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss cohort study. Clin Infect Dis 2007, 45:111-119. 10.1086/518619, 17554711, Swiss HIV Cohort Study.
5. D:A:D Study Group Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008, 371:1417-1426. 10.1016/S0140-6736(08)60423-7, 2688660, 18387667, D:A:D Study Group.
6. Butt AA, McGinnis K, Rodriguez-Barradas MC, Crystal S, Simberkoff M, Goetz Bidwell M, Leaf D, Justice C, . Veterans Aging Cohort Study HIV infection and the risk of diabetes mellitus. AIDS 2009, 23:1227-1234. 10.1097/QAD.0b013e32832bd7af, 19444074, Veterans Aging Cohort Study.
7. Pacheco AG, Tuboi SH, Faulhaber JC, Harrison LH, Schechter M. Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil. PLoS ONE 2008, 3:e1531. 10.1371/journal.pone.0001531, 2211396, 18231611.
8. Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR, . Triservice AIDS Clinical Consortium Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006, 41:194-200. 10.1097/01.qai.0000179459.31562.16, 16394852, Triservice AIDS Clinical Consortium.
9. Smit C, Geskus R, Walker S, Sabin C, Coutinho R, Porter K, Prins M, . CASCADE Collaboration Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006, 20:741-749. 10.1097/01.aids.0000216375.99560.a2, 16514305, CASCADE Collaboration.
10. Selik RM, Byers RH, Dworkin MS. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002, 29:378-387.
11. Serraino D, Zucchetto A, Suligoi B, Bruzzone S, Camoni L, Boros S, De Paoli A, Dal Maso L, Franceschi S, Rezza G. Survival after AIDS in Italy, 1999-2006: a population-based study. J Acquir Immune Defic Syndr 2009, 52:99-105. 10.1097/QAI.0b013e3181a4f663, 19448558.
12. Ancelle-Park R. Expanded European AIDS case definition. Lancet 1993, 341:441. 10.1016/0140-6736(93)93040-8, 8094208.
13. Conti S, Masocco M, Pezzotti P, Toccaceli V, Vichi M, Boros S, Urciuoli R, Valdarchi C, Rezza G. Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses. J Acquir Immune Defic Syndr 2000, 25:451-458. 10.1097/00042560-200012150-00011, 11141245.
14. Conti S, Farchi G, Galletti A, Masocco M, Napoli PA, Pezzotti P, Rezza G, Toccaceli V, Cariani G. La notifica della mortalità per AIDS in Italia (1992): qualità della certificazione e sottonotifica. Giornale italiano dell'AIDS 1997, 8:12-16.
15. Breslow NE, Day NE. Statistical methods in cancer research. Volume II: The design and analysis of cohort studies 1987, IARC Sci. Publ. N.82. Lyon: IARC.
16. Serraino D, Dal Maso L, De Paoli A, Zucchetto A, Buzzone S, Camoni L, Suligoi B. On changes in cancer mortality among HIV-infected patients. Is there an excess risk of death for pancreatic cancer?. Clin Infect Dis 2009, 49:481-482. 10.1086/600823, 19586399.
17. Huxley R, Ansary-Moghaddam A, de Gonzalez Berrington A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005, 92:2076-2083. 10.1038/sj.bjc.6602619, 2361795, 15886696.
18. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, Russo A, Intrieri T, Vercelli M, Zambon P, Tagliabue G, Zanetti R, Federico M, Limina RM, Mangone L, De Lisi V, Stracci F, Ferretti S, Piffer S, Budroni M, Donato A, Giacomin A, Bellù F, Fusco M, Madeddu A, Vitarelli S, Tessandori R, Tumino R, Suligoi B, Franceschi S, . Cancer and AIDS Registries Linkage (CARL) Study Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009, 100:840-847. 10.1038/sj.bjc.6604923, 2653754, 19223894, Cancer and AIDS Registries Linkage (CARL) Study.